Gastroesophageal reflux (GER) happens when stomach contents come back up into the esophagus. Stomach acid that touches the lining of the esophagus can cause heartburn, also called acid indigestion.

DelveInsight's, “Gastroesophageal Reflux Disease Pipeline Insight, 2025,” report provides comprehensive insights about 10+ companies and 12+ pipeline drugs in Gastroesophageal Reflux Disease (GERD) ...

Gastroesophageal reflux disease (GERD) is a common condition in clinical practice, and results from the backward flow of stomach and duodenal contents into the esophagus and higher structures.

Objective: To investigate the efficacy of acid suppressant drugs in the empirical treatment of gastroesophageal reflux disease (GERD) and in the treatment of endoscopy-negative reflux disease (ENRD).

Gastroesophageal reflux disease (GERD), also known as gastro oesophageal reflux disease, is more than just the occasional heartburn—it’s a chronic condition where stomach acid keeps flowing back into ...

Surgical Gastroenterologist Dr Anshuman Kaushal from Apollo Hospital has warned that persistent acidity and heartburn may actually indicate Gastroesophageal Reflux Disease (GERD), a serious condition ...

The "Gastroesophageal Reflux Disease Therapeutics Market Size, Share & Trends Analysis Report By Drug Type, By Region, And Segment Forecasts, 2025 - 2030" report has been added to ...

"Gastroesophageal Reflux Disease (GERD) Market"The market for Gastroesophageal Reflux Disease (GERD) is poised for growth during the forecast period (2024-2034), due to escalating prevalence, aging ...

Merit Medical Systems Inc. acquired the Esophyx Z+ device from Endogastric Solutions Inc. for $105 million in cash, adding a durable, non-pharmacological treatment for gastroesophageal reflux disease ...